Literature DB >> 1722213

The pro-alpha 1(V) collagen chain. Complete primary structure, distribution of expression, and comparison with the pro-alpha 1(XI) collagen chain.

D S Greenspan1, W Cheng, G G Hoffman.   

Abstract

We have isolated overlapping cDNA clones from human and hamster libraries which comprise the entire coding sequences for the prepro-alpha 1(V) collagen chains of both species. The translated polypeptide has a signal peptide of 36 amino acids, a central triple helical domain of 338 uninterrupted Gly-X-Y triplets, and 266 amino acids which comprise the C-telopeptide and propeptide. The N-propeptide and telopeptide are comprised of 522 residues in humans and 524 residues in hamsters. The cDNA-derived pro-alpha 1(V) amino acid sequences exhibit a variety of structural features characteristic of fibrillar collagens. Pro-alpha 1(V) is found to be unique among fibrillar collagen chains, however, in lacking potential cross-linking lysyl residues in either telopeptide, and in possessing potential N-asparaginyl-linked carbohydrate attachment sites in its N-propeptide. Of particular interest is the strong homology found between the pro-alpha 1(V) and pro-alpha 1(XI) collagen chains in most domains, with the notable exception of a subdomain in the globular region of the N-propeptide. RNase protection analysis of RNA with a variety of pro-alpha 1(V) cDNA-derived riboprobes indicates a broad distribution of expression of the pro-alpha 1(V) chain in tissues and suggests that transcripts encoding the pro-alpha 1(V) chain and the putative pro-alpha 1'(V) chain are not products of the same gene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722213

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II).

Authors:  U Schwarze; M Atkinson; G G Hoffman; D S Greenspan; P H Byers
Journal:  Am J Hum Genet       Date:  2000-05-04       Impact factor: 11.025

2.  Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II.

Authors:  A De Paepe; L Nuytinck; I Hausser; I Anton-Lamprecht; J M Naeyaert
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

3.  COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS.

Authors:  R J Wenstrup; J B Florer; M C Willing; C Giunta; B Steinmann; F Young; M Susic; W G Cole
Journal:  Am J Hum Genet       Date:  2000-04-24       Impact factor: 11.025

4.  Proteomic analysis of Col11a1-associated protein complexes.

Authors:  Raquel J Brown; Christopher Mallory; Owen M McDougal; Julia Thom Oxford
Journal:  Proteomics       Date:  2011-11-23       Impact factor: 3.984

5.  Collagen V localizes to pericellular sites during tendon collagen fibrillogenesis.

Authors:  Simone M Smith; Guiyun Zhang; David E Birk
Journal:  Matrix Biol       Date:  2013-08-15       Impact factor: 11.583

6.  Transcriptional promoter of the human alpha 1(V) collagen gene (COL5A1).

Authors:  S Lee; D S Greenspan
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

7.  Bilateral consecutive rupture of the quadriceps tendon in a man with BstUI polymorphism of the COL5A1 gene.

Authors:  Umile Giuseppe Longo; Vito Fazio; Maria Luana Poeta; Carla Rabitti; Francesco Franceschi; Nicola Maffulli; Vincenzo Denaro
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-12-03       Impact factor: 4.342

8.  Comprehensive mass spectrometric mapping of the hydroxylated amino acid residues of the α1(V) collagen chain.

Authors:  Chenxi Yang; Arick C Park; Nicholas A Davis; Jason D Russell; Byoungjae Kim; David D Brand; Matthew J Lawrence; Ying Ge; Michael S Westphall; Joshua J Coon; Daniel S Greenspan
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

9.  Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I.

Authors:  Kazuhiko Takahara; Ulrike Schwarze; Yasutada Imamura; Guy G Hoffman; Helga Toriello; Lynne T Smith; Peter H Byers; Daniel S Greenspan
Journal:  Am J Hum Genet       Date:  2002-07-17       Impact factor: 11.025

10.  A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families.

Authors:  N P Burrows; A C Nicholls; A J Richards; C Luccarini; J B Harrison; J R Yates; F M Pope
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.